Chapter 5. Polyepitope Vaccines

  1. Rimas Orentas PhD3,
  2. James W. Hodge PhD4 and
  3. Bryon D. Johnson PhD5
  1. Corey Smith PhD1 and
  2. Rajiv Khanna PhD2

Published Online: 1 MAR 2007

DOI: 10.1002/9780470170113.ch5

Cancer Vaccines and Tumor Immunity

Cancer Vaccines and Tumor Immunity

How to Cite

Smith, C. and Khanna, R. (2008) Polyepitope Vaccines, in Cancer Vaccines and Tumor Immunity (eds R. Orentas, J. W. Hodge and B. D. Johnson), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470170113.ch5

Editor Information

  1. 3

    Departments of Pediatrics, Medicine, Microbiology and Molecular Genetics, Medical College of Wisconsin and the Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI, USA

  2. 4

    Department of Medical Biology, University of Tennessee Medical Center and Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

  3. 5

    Department of Pediatrics, Medical College of Wisconsin and the Children's Research Institute, Children's Hospital of Wisconsin., Milwaukee, WI, USA

Author Information

  1. 1

    Australian Centre for Vaccine Development, Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Herston, QLD, Australia

  2. 2

    Australian Centre for Vaccine Development, Tumour Immunology Laboratory, Principal Research Fellow (NH&MRC) Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Herston, QLD, Australia

Publication History

  1. Published Online: 1 MAR 2007
  2. Published Print: 22 JAN 2008

ISBN Information

Print ISBN: 9780470074749

Online ISBN: 9780470170113

SEARCH

Keywords:

  • cytotoxic T lymphocytes (CTLs);
  • EBV-associated malignancies - polyepitope-based treatment;
  • polyepitope-based immunization strategies

Summary

This chapter contains sections titled:

  • Introduction

  • Peptide-Based Vaccines and Identification of CTL Peptide Targets

  • Vehicles for Delivery of Peptide-Based Vaccines

  • Peptide-Based Vaccines for Treatment of Human Diseases

  • Polyepitope Technology

  • Polyepitope-Based Treatment of EBV-Associated Malignancies

  • Clinical Studies on Polyepitope Vaccine for other Human Diseases

  • References